Stenocins: Novel modular bacteriocins from opportunistic pathogen Stenotrophomonas maltophilia

J Biotechnol. 2022 Jun 10:351:9-12. doi: 10.1016/j.jbiotec.2022.04.006. Epub 2022 Apr 15.

Abstract

Stenotrophomonas maltophilia is a global emerging pathogenic bacillus that is highly drug resistant and known to cause nosocomial infections in immunocompromised hosts. Because of their novel modes of action, bacteriocins are being proposed as alternatives to antibiotics for the treatment of infections caused by multidrug resistant bacteria. This study is the first report of modular bacteriocins called stenocins, which were discovered in the genomes of S. maltophilia. These two novel peptidoglycan-degrading bacteriocins were identified, cloned, and expressed in plants. We demonstrate that plant-expressed stenocins are functional and inhibit the growth of Stenotrophomonas strains in vitro.

Keywords: Antibiotic resistance; Antimicrobials; Colicin M-like bacteriocins; Nicotiana benthamiana; Plant-produced.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteriocins* / genetics
  • Bacteriocins* / pharmacology
  • Drug Resistance, Multiple, Bacterial
  • Gram-Negative Bacterial Infections* / drug therapy
  • Gram-Negative Bacterial Infections* / microbiology
  • Humans
  • Stenotrophomonas maltophilia* / genetics

Substances

  • Anti-Bacterial Agents
  • Bacteriocins